KRT128P

Across TCGA pan-cancer cohorts, KRT128P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated KRT128P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher KRT128P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRT128P expression acts as an unfavorable survival marker.

UCS, READ, and THYM are the cancer types where KRT128P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	All	0.068	0.524	<.001	144	view →
READ	OS	Tertile	II,III,IV	0.056	0.934	<.001	54	view →
THYM	OS	Tertile	II,III,IV	0.186	0.906	.003	36	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
UCEC	OS	Tertile	All	0.782	0.928	.028	6	view →
SARC	OS	Tertile	All	0.190	0.599	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

KRT128P–UCS (DFS)

Open the UCS breakdown →